Candriam SCA’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.43M | Hold |
14,949
| – | – | 0.01% | 555 |
|
|
2026
Q1 | $1.55M | Hold |
14,949
| – | – | 0.01% | 553 |
|
|
2025
Q4 | $1.51M | Buy |
14,949
+9,322
| +166% | +$1.01M | 0.01% | 539 |
|
|
2025
Q3 | $694K | Sell |
5,627
-4,954
| -47% | -$615K | ﹤0.01% | 601 |
|
|
2025
Q2 | $1.27M | Sell |
10,581
-2,574
| -20% | -$343K | 0.01% | 569 |
|
|
2025
Q1 | $1.94M | Sell |
13,155
-2,221
| -14% | -$339K | 0.01% | 503 |
|
|
2024
Q4 | $2.5M | Buy |
15,376
+2,179
| +17% | +$356K | 0.01% | 464 |
|
|
2024
Q3 | $2.15M | Sell |
13,197
-560
| -4% | -$83K | 0.01% | 494 |
|
|
2024
Q2 | $1.88M | Buy |
13,757
+665
| +5% | +$92.3K | 0.01% | 497 |
|
|
2024
Q1 | $2M | Buy |
13,092
+1,833
| +16% | +$274K | 0.01% | 510 |
|
|
2023
Q4 | $1.61M | Sell |
11,259
-31,607
| -74% | -$4.21M | 0.01% | 523 |
|
|
2023
Q3 | $5.62M | Buy |
42,866
+29,530
| +221% | +$4.49M | 0.04% | 296 |
|
|
2023
Q2 | $2.12M | Sell |
13,336
-6,451
| -33% | -$1.04M | 0.02% | 481 |
|
|
2023
Q1 | $2.88M | Buy |
19,787
+32
| +0.2% | +$4.8K | 0.02% | 492 |
|
|
2022
Q4 | $2.77M | Sell |
19,755
-1,502
| -7% | -$213K | 0.02% | 511 |
|
|
2022
Q3 | $2.73M | Buy |
21,257
+9,433
| +80% | +$1.36M | 0.02% | 517 |
|
|
2022
Q2 | $1.67M | Sell |
11,824
-324
| -3% | -$46.3K | 0.01% | 541 |
|
|
2022
Q1 | $1.69M | Sell |
12,148
-3,008
| -20% | -$461K | 0.01% | 578 |
|
|
2021
Q4 | $2.64M | Buy |
15,156
+2,533
| +20% | +$422K | 0.02% | 490 |
|
|
2021
Q3 | $2.09M | Sell |
12,623
-6,554
| -34% | -$1.13M | 0.01% | 570 |
|
|
2021
Q2 | $4.49M | Sell |
19,177
-106,004
| -85% | -$19.3M | 0.03% | 425 |
|
|
2021
Q1 | $24.3M | Hold |
125,181
| – | – | 0.2% | 127 |
|
|
2020
Q4 | $25.3M | Buy |
125,181
+99,577
| +389% | +$20.6M | 0.2% | 128 |
|
|
2020
Q3 | $5.38M | Buy |
25,604
+14,320
| +127% | +$3.19M | 0.05% | 344 |
|
|
2020
Q2 | $2.48M | Sell |
11,284
-309
| -3% | -$61.7K | 0.03% | 452 |
|
|
2020
Q1 | $1.74M | Hold |
11,593
| – | – | 0.02% | 558 |
|
|
2019
Q4 | $1.78M | Sell |
11,593
-570
| -5% | -$85.2K | 0.02% | 575 |
|
|
2019
Q3 | $1.85M | Buy |
12,163
+843
| +7% | +$133K | 0.02% | 500 |
|
|
2019
Q2 | $1.73M | Hold |
11,320
| – | – | 0.02% | 552 |
|
|
2019
Q1 | $1.82M | Buy |
11,320
+962
| +9% | +$149K | 0.02% | 526 |
|
|
2018
Q4 | $1.6M | Sell |
10,358
-1,191
| -10% | -$186K | 0.02% | 504 |
|
|
2018
Q3 | $1.74M | Buy |
11,549
+630
| +6% | +$89.5K | 0.02% | 532 |
|
|
2018
Q2 | $1.48M | Buy |
10,919
+39
| +0.4% | +$4.81K | 0.02% | 538 |
|
|
2018
Q1 | $1.45M | Sell |
10,880
-117
| -1% | -$15.7K | 0.02% | 534 |
|
|
2017
Q4 | $1.64M | Buy |
10,997
+398
| +4% | +$54.2K | 0.03% | 492 |
|
|
2017
Q3 | $1.4M | Buy |
10,599
+403
| +4% | +$54.1K | 0.02% | 517 |
|
|
2017
Q2 | $1.36M | Sell |
10,196
-195
| -2% | -$26.3K | 0.03% | 530 |
|
|
2017
Q1 | $1.4M | Buy |
10,391
+1,815
| +21% | +$235K | 0.03% | 508 |
|
|
2016
Q4 | $1.03M | Buy |
8,576
+784
| +10% | +$92.5K | 0.02% | 512 |
|
|
2016
Q3 | $975K | Buy |
7,792
+1,958
| +34% | +$256K | 0.02% | 501 |
|
|
2016
Q2 | $807K | Sell |
5,834
-67,255
| -92% | -$8.72M | 0.02% | 479 |
|
|
2016
Q1 | $9.16M | Sell |
73,089
-205,829
| -74% | -$26.2M | 0.23% | 116 |
|
|
2015
Q4 | $35.4M | Buy |
278,918
+203,205
| +268% | +$25.2M | 0.95% | 20 |
|
|
2015
Q3 | $8.75M | Buy |
75,713
+67,890
| +868% | +$7.62M | 0.21% | 137 |
|
|
2015
Q2 | $814K | Buy |
7,823
+5,592
| +251% | +$603K | 0.02% | 474 |
|
|
2015
Q1 | $246K | Hold |
2,231
| – | – | 0.01% | 607 |
|
|
2014
Q4 | $232K | Buy |
+2,231
| New | +$223K | ﹤0.01% | 591 |
|
Other funds holding CLX
Candriam SCA's CLX Position: Q2 2026 in Review
Candriam SCA held its Clorox (CLX) position steady in Q2 2026 at 14,949 shares worth $1.43M. The position accounts for 0.01% of the portfolio, ranked #555.
Candriam SCA first reported a position in CLX in Q4 2014 and has held it in 47 quarters since. The position peaked at $35.4M in Q4 2015. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Candriam SCA held 14,949 shares of Clorox worth $1.43M as of Q2 2026.
- Candriam SCA left its Clorox share count unchanged in Q2 2026.
- Clorox made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #555 holding.
- Candriam SCA first reported a position in Clorox in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Clorox position peaked at $35.4M in Q4 2015.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.